Accelerated Disc Resorption: 5 Cutting-Edge Options That Help Herniated Discs Heal Faster

Accelerated Disc Resorption is an exciting new frontier in spine care that focuses on helping herniated discs shrink faster using biologic and enzyme-based therapies. While some disc herniations resolve naturally over time, others persist and cause months of disabling pain. Emerging treatments like platelet-rich plasma (PRP), Wharton’s Jelly, and condoliase injections are now being studied for their ability to speed up the body’s natural clean-up process and relieve nerve root pressure without surgery.

At our practice, we believe that patients deserve to understand all available options—especially when it comes to cutting-edge, non-surgical care. In this article, we’ll walk you through the science behind accelerated disc resorption, the role of your immune system, and five evidence-based approaches that may help your body heal faster after a disc herniation.

What Is Accelerated Disc Resorption?

Accelerated Disc Resorption refers to the intentional use of therapies that help the body eliminate herniated disc fragments more quickly. While many disc herniations shrink naturally over several months, this process can be unpredictable and painfully slow. Medical research has uncovered how certain injections may speed up the body’s own clean-up mechanisms, particularly in cases of large extruded or sequestered discs.

When the jelly-like center of a spinal disc (called the nucleus pulposus) herniates through the tough outer ring, the body responds by treating it like a foreign invader. Immune cells such as macrophages are activated and begin digesting the leaked disc material. This process is aided by enzymes like matrix metalloproteinases (MMPs), which break down the disc’s structural proteins. The end result? The herniated disc fragment begins to shrink, relieving pressure on nearby spinal nerves. This process is simply called as disc resorption.

Unfortunately, this immune response can take many months to fully resolve. That’s where accelerated disc resorption therapies come in—by boosting or mimicking the body’s cleanup response, they may help relieve nerve compression and reduce pain faster than waiting for natural healing alone.

Conventional Treatment Options for Disc Herniation

Most patients with a herniated disc are initially treated with a combination of physical therapy, chiropractic care, acupuncture, and medications. These strategies can help reduce inflammation, improve spinal stability, and allow time for the body to heal. In many cases, conservative care is enough—but not always.

Typical treatments include:

• Physical Therapy: Core strengthening and postural correction can reduce mechanical stress on the spine.
• Chiropractic and Acupuncture: Some patients find relief through spinal adjustments or neuromodulation techniques.
• Medications: Oral steroids, muscle relaxants, and anti-inflammatories are often used in early treatment.
• Epidural Steroid Injections: These injections provide short-term relief by reducing nerve inflammation. Learn more about epidural injections.
• Surgical Options: For severe or persistent symptoms, surgical decompression may be recommended. These include endoscopic discectomy, minimally invasive microdiscectomy, or open surgery in more complex cases.

While these options can be effective, they often focus on symptom control rather than enhancing the body’s ability to resorb the herniated disc material itself.

This leads to a crucial and exciting question: if your body already has the ability to shrink a herniated disc through immune mechanisms… could we help it do so more effectively? The answer is yes—and this is precisely the philosophy behind Accelerated Disc Resorption therapies offered at SpinePain Solutions.

Studies show that spontaneous regression of lumbar disc herniations occurs in over 66% of patients with extruded or sequestered discs, often taking 6 to 12 months or more. Our goal is to ethically and scientifically support this natural process using regenerative medicine, advanced biologics, and targeted enzymes—all designed to help your body heal faster and reduce pain sooner.

1. Intradiscal PRP Therapy

One of the most promising methods for Accelerated Disc Resorption is intradiscal platelet-rich plasma (PRP) therapy. PRP is created by drawing a small sample of your blood, spinning it in a specialized centrifuge to concentrate healing platelets, and injecting it directly into the damaged disc under X-ray guidance. These platelets release a powerful mix of growth factors and anti-inflammatory signals that may stimulate the body’s immune system to resorb the herniated material more efficiently.

In patients with discogenic pain, early annular tears, or small to moderate herniations, PRP has shown the ability to:

• Reduce inflammation inside the disc
• Promote disc hydration and repair
• Attract macrophages to assist with resorption
• Relieve nerve root irritation

Multiple studies support the use of intradiscal PRP. In a double-blind randomized trial published in PM&R (2016), Tuakli-Wosornu et al. found that patients who received PRP experienced significantly greater improvements in pain and function compared to saline controls. A follow-up study in Spine Journal (2020) suggested that PRP may also improve long-term disc hydration, especially when used early.

For suitable candidates, PRP offers a safe, outpatient-based method to enhance disc healing without steroids or surgery. It is most effective in patients with contained disc injuries or early-stage degeneration. We often perform this treatment under local anesthesia and fluoroscopic guidance at our Long Island spine centers.

2. PRP Combined with Wharton’s Jelly: A Synergistic Approach

For patients with more advanced disc degeneration or larger herniations, combining PRP with a regenerative tissue matrix such as Wharton’s Jelly may offer additional benefits. Wharton’s Jelly, derived from donated umbilical cord tissue, is rich in extracellular matrix components, hyaluronic acid, collagen, and bioactive peptides that help support tissue repair and modulate inflammation.

When paired with platelet-rich plasma, this combination therapy can enhance the immune signaling environment within the disc and potentially speed up macrophage-led resorption of herniated material. It also offers mechanical cushioning and extracellular support to the damaged disc space.

At SpinePain Solutions, we use only high-quality, AATB-compliant, 361-registered Wharton’s Jelly products in carefully selected patients. Our preferred approach involves injecting:

• 1 mL of leukocyte-poor PRP (using our EmCyte system)
• + 1 mL of cryopreserved Wharton’s Jelly matrix
• Directly into the affected disc under fluoroscopic guidance

This technique is reserved for patients who have failed traditional care and prefer a non-surgical, biologically-driven alternative. It is especially suited for patients with:

• Contained disc herniations or early sequestration
• Recurrent disc pain without severe stenosis
• Stable disc height and limited Modic changes

Important note: While Wharton’s Jelly is compliant with current FDA guidelines for 361 HCT/P products, its use in spinal applications is considered investigational. We provide detailed consent and counseling before proceeding with this treatment option. Patients are never pressured—we aim to educate, not sell.

3. Condoliase (SI-6603): Enzyme-Based Disc Shrinking

One of the most innovative tools in the field of Accelerated Disc Resorption is a bioenzyme called condoliase, also known by its investigational name SI-6603. Developed by Seikagaku Corporation, this enzyme selectively degrades glycosaminoglycans (GAGs)—the water-binding molecules inside the nucleus pulposus of a spinal disc.

When a disc herniates, the gelatinous core bulges outward and may press against nearby nerve roots. By breaking down the GAGs inside the disc, condoliase reduces its internal volume and turgor pressure. This leads to shrinking of the herniation and decompression of the affected nerve.

Key details:

• Mechanism: Targets chondroitin sulfate and hyaluronic acid without damaging nerve tissue or blood vessels.
• Administration: Injected directly into the herniated disc under imaging guidance—usually in a single session.
• Approval Status: Marketed in Japan under the name HERNICORE; currently under FDA review in the U.S.
• Clinical Trials: Phase III trials showed statistically significant improvement in leg pain and disc morphology. Positive results were recently presented by Ferring Pharmaceuticals, the global license holder.

Condoliase may be a game-changer for patients with large, symptomatic disc herniations who wish to avoid surgery. Unlike steroids or regenerative treatments, this enzyme works by directly reducing the size of the disc protrusion. However, it is still considered an investigational therapy in the U.S. and is not yet widely available outside clinical trials.

At SpinePain Solutions, we closely monitor the progress of condoliase’s regulatory journey and are prepared to integrate it when FDA approval is granted. Until then, patients are encouraged to learn about other biologic options that aim to support natural disc healing.

4. Perineural PRP or Exosome Injections

Not all patients are candidates for direct disc injections. In cases where the disc herniation is extruded or sequestered—and where radicular pain is more dominant than axial back pain—targeting the perineural space with immune-modulating biologics may offer meaningful relief.

Perineural PRP injections involve delivering a concentrated dose of platelet-derived growth factors around the inflamed nerve root, often via a transforaminal or interlaminar epidural approach. This technique is guided by live fluoroscopy and avoids puncturing the disc itself.

Alternatively, extracellular vesicles (exosomes) derived from placental or amniotic sources may be used in select patients to deliver nano-scale immunomodulatory molecules that reduce neuroinflammation and support tissue recovery.

The proposed mechanisms include:

• Shifting macrophage polarization from pro-inflammatory (M1) to anti-inflammatory (M2) states
• Downregulating cytokines such as TNF-α and IL-1β that inhibit disc resorption
• Improving oxygenation and nutrient delivery to the nerve-damaged microenvironment

While this technique does not directly reduce disc volume, it may enhance the surrounding healing conditions that permit the disc to shrink naturally over time. In our practice, this is a valuable option for patients who:

• Have a history of spine surgery and wish to avoid further intervention
• Are poor candidates for intradiscal injection due to annular disruption or fibrosis
• Are looking for lower-risk outpatient alternatives to surgery

Our individualized care plans at SpinePain Solutions incorporate perineural biologics when appropriate—always with full transparency and data-driven expectations.

Comparative Data: PRP vs. BMAC, SVF, and Steroid Injections

As interest in Accelerated Disc Resorption grows, more studies are comparing different biologic treatments to determine which offers the best combination of safety, efficacy, and durability. Not all regenerative therapies are the same—and choosing the right approach depends on patient factors, disc morphology, and available resources.

PRP vs. Bone Marrow Aspirate Concentrate (BMAC)

A multicenter, prospective, randomized crossover trial by Navani et al. enrolled 40 patients with degenerative disc disease and MRI-confirmed pathology. Participants received either intradiscal saline (n = 12), PRP (n = 13), or BMAC (n = 15). Both PRP and BMAC groups showed statistically significant improvements in pain and function compared to placebo, with no serious adverse events recorded. These findings suggest that autologous cell-based therapies can play a meaningful role in disc resorption and symptom control when applied under image guidance and with proper selection criteria.

Stromal Vascular Fraction (SVF) + PRP

Another intriguing approach to accelerated disc resorption involves the use of stromal vascular fraction (SVF), a cell-rich mixture derived from adipose tissue. SVF contains mesenchymal stem cells (MSCs), endothelial cells, pericytes, immune cells, and regenerative peptides. Comella et al. conducted a study in which 15 patients received intradiscal injections of SVF suspended in PRP following lipoaspiration and enzymatic processing. After 12 months, patients demonstrated significant improvements in pain, spinal flexion, and quality of life, without serious complications. Although disability and depression scores remained unchanged, the results support further investigation into SVF as a supportive biologic tool.

Biologics vs. Steroid Injections

Traditional epidural steroid injections can provide short-term relief but do not address disc morphology. Steroids may also impair long-term disc health by inhibiting matrix repair. In contrast, regenerative injections like PRP or BMAC are designed to stimulate immune-mediated resorption and structural repair. For patients with recurrent symptoms or large herniations, regenerative options may offer greater durability without the catabolic effects of corticosteroids.

The Role of Platelet Concentration in PRP

Not all PRP is created equal. The concentration of platelets significantly affects its therapeutic potential. Studies suggest that PRP preparations with 5x to 10x baseline platelet counts offer more robust anti-inflammatory and regenerative effects. At SpinePain Solutions, we use the EmCyte system to customize platelet concentration for disc injections, maximizing the biologic potential of your own cells in supporting accelerated disc resorption.

5. Investigational Therapies on the Horizon

The field of spine biologics is evolving rapidly, with several companies and academic groups exploring new ways to promote Accelerated Disc Resorption. While these approaches remain investigational in the U.S., they represent the future of non-surgical disc care and may offer hope to patients with chronic disc pathology.

Exosome-Based Disc Modulation

Exosomes are nano-sized vesicles secreted by stem cells that carry growth factors, anti-inflammatory cytokines, and genetic material. Research is underway to harness intradiscal exosomes to reduce inflammation and encourage the resorption of herniated disc fragments. These therapies may also stimulate the production of healthy matrix proteins and prevent degeneration.

Gene-Modified Mesenchymal Stem Cells (MSCs)

Companies like DiscGenics and Mesoblast are exploring the use of gene-modified stem cells that are optimized to release anti-catabolic and regenerative proteins. Their injectable cell-based therapies have shown early promise in improving disc height and reducing inflammation in phase I/II trials.

Macrophage Reprogramming Technologies

Recent preclinical studies have shown that the phenotype of macrophages—specifically their switch from M1 (pro-inflammatory) to M2 (repair-promoting)—plays a pivotal role in disc healing. Scientists are now developing injectable agents and biologic scaffolds designed to enhance this switch, potentially speeding up natural disc clean-up in a safe and targeted way.

While these options are not yet FDA-approved for routine use, we continuously monitor new developments and remain committed to offering the most advanced, evidence-based care as regulations and research evolve.

Why This Matters: Empowered, Ethical Spine Care

At SpinePain Solutions, we believe in delivering care that is not only clinically advanced but also ethically grounded. We do not market therapies as guaranteed solutions. Instead, we offer a science-based explanation of all available options—including both traditional and emerging treatments—so that you can make the right decision for your body, your health, and your budget.

We recognize that many patients are cautious about newer treatments, especially when they involve out-of-pocket costs. That’s why our goal is to educate first, and let the decision follow. Every patient receives a thorough consultation and a personalized care plan tailored to their specific disc condition, imaging findings, and lifestyle needs.

Whether you pursue physical therapy, a well-timed epidural injection, or explore regenerative options like PRP or Wharton’s Jelly, our team is here to support your journey. And if you’re not a candidate for these approaches, we’ll tell you that too—with honesty, transparency, and your long-term health in mind.

Helping a disc herniation shrink or disc resorption process is often possible. Helping patients understand their options is always essential.

Frequently Asked Questions